The International Cartilage Regeneration & Joint Preservation Society selected clinical research performed by the Mizzou BioJoint® Center team to receive the Best Rated Abstract award at a special focus conference held Dec. 13-14, 2018 in Milan, Italy. This conference entitled– I’m not Ready for Metal – included 500 international surgeons and researchers sharing the latest state-of-the-art joint preservation techniques that can provide safe and effective alternatives to traditional artificial joint replacement.
The research presentation, titled, “Initial Outcomes for Bipolar Osteochondral Allograft Transplantation in the Knee Using Novel Techniques” was authored by James P. Stannard, MD, and James L. Cook, DVM, PhD, OTSC and was presented by Lasun Oladeji, MD, MS, senior research specialist. Based on more than a decade of work originating in the Thompson Laboratory for Regenerative Orthopaedics, this clinical outcomes study concludes that osteochondral allografts used in knee surgery preserved using the Missouri Osteochondral Preservation System (MOPSSM) are safe and can yield highly functional outcomes for at least 2 years after surgery.
Dr. Oladeji also represented the lab and department by presenting the results of 3 other studies during the conference.
Related News
